FDA Qualified Infectious Disease Product Designations
This article was originally published in Pharmaceutical Approvals Monthly
Executive Summary
Pharmaceutical Approvals Monthly introduces a new feature tracking anti-infective product candidates that have received a Qualified Infectious Disease Product Designation from FDA. QIDP status was introduced in FDASIA to encourage development of treatments for serious or life-threatening infections caused by bacteria or fungi.